DR. REDDY'S LABORATO

500124
End-of-day quote. End-of-day quote  - 11/26
4898.8INR +1.92%
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: March 2020 2021
Net sales1 174 600192 864
EBITDA1 46 43147 319
Operating profit (EBIT)1 28 47034 082
Operating Margin 16,3%17,7%
Pre-Tax Profit (EBT)1 18 03235 949
Net income1 19 49827 597
Net margin 11,2%14,3%
EPS2 117166
Dividend per Share2 25,025,8
Last update 06/09/202011/25/2020
1 INR in Million
2 INR
Estimates
Finances - Leverage
Fiscal Period: March 2020 2021
Net Debt1 --
Net Cash position1 3 72910 068
Leverage (Debt / EBITDA) -0,08x-0,21x
Free Cash Flow1 24 99512 555
ROE (Net Profit / Equities) 13,2%16,4%
Shareholders' equity1 147 589168 005
ROA (Net Profit / Asset) 8,52%10,7%
Assets1 228 823257 648
Book Value Per Share2 9351 068
Cash Flow per Share2 180212
Capex1 4 84617 870
Capex / Sales 2,78%9,27%
Last update 06/09/202011/22/2020
1 INR in Million
2 INR
Estimates
Balance Sheet Analysis
Financial Ratios
Size 2021e 2022e
Capitalization 812 674 M INR -
Entreprise Value (EV) 802 606 M INR 783 051 M INR
Valuation 2021e 2022e
P/E ratio (Price / EPS) 29,6x 25,0x
Capitalization / Revenue 4,21x 3,76x
EV / Revenue 4,16x 3,71x
EV / EBITDA 17,0x 14,8x
Yield (DPS / Price) 0,53% 0,58%
Price to book (Price / BVPS) 4,59x 3,97x
Profitability 2021e 2022e
Operating Margin (EBIT / Sales) 17,7% 18,5%
Operating Leverage (Delta EBIT / Delta Sales) 1,88x 1,44x
Net Margin (Net Profit / Revenue) 14,3% 15,1%
ROA (Net Profit / Asset) 10,7% 10,4%
ROE (Net Profit / Equities) 16,4% 16,8%
Rate of Dividend 15,5% 14,5%
Balance Sheet Analysis 2021e 2022e
CAPEX / Sales   9,27% 4,97%
Cash Flow / Sales 18,2% 16,5%
Capital Intensity (Assets / Sales) 1,34x 1,46x
Financial Leverage (Net Debt / EBITDA) - -
Price Earning Ratio
EPS & Dividend